儿童抗N-甲基-D-天冬氨酸受体脑炎住院康复早期功能结局
该回顾性图表综述纳入27例接受强化住院神经康复的儿童抗NMDAR脑炎患者,入院至出院WeeFIM总DFQ评分从平均28.6显著提高至54.3(P<0.01),但出院时仍存在功能缺陷。发病年龄较小、癫痫发作及治疗次数较多与出院时功能结局较差相关,而开始治疗时间与早期功能结局无关。
要点
- 儿童抗NMDAR脑炎住院康复期间WeeFIM DFQ评分显著改善(P<0.01)。
- 出院时平均WeeFIM总DFQ为54.3,仍存在持续功能缺陷。
- 发病年龄小、癫痫发作和治疗次数多与出院功能结局较差相关。
核心结论
- 儿童抗NMDAR脑炎患者住院康复期间功能显著改善,但出院时仍有持续缺陷,需持续监测和干预。
研究设计与样本
- 回顾性图表综述,纳入27例接受强化住院神经康复的儿童抗NMDAR脑炎患者。
主要发现
- 患者症状发作平均年龄10.6岁(范围2-18岁),从症状发作到治疗平均27.2天(范围5-91天)。
- WeeFIM总DFQ评分从入院平均28.6(范围15.0-62.6)提高至出院平均54.3(范围14.2-91.9),差异有统计学意义(P<0.01)。
- 发病年龄较小、癫痫发作及治疗次数较多与出院时功能结局较差相关。
- 开始治疗时间与早期功能结局无关。
关键数值与推荐
- WeeFIM总DFQ评分入院平均28.6(范围15.0-62.6),出院平均54.3(范围14.2-91.9),P<0.01。
临床怎么用
- 儿童抗NMDAR脑炎住院康复可显著改善功能,出院时应继续监测并制定持续干预计划。
- 对发病年龄小、有癫痫发作或治疗次数多的患儿,应关注出院时功能结局较差的风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aims of the current study were to characterize the demographic and clinical presentation of pediatric patients diagnosed with anti-N-methyl-D-aspartate receptor encephalitis who require inpatient rehabilitation, to examine early functional outcomes, and to investigate predictors of early recovery. DESIGN: A retrospective chart review was conducted for 27 pediatric patients diagnosed with anti-N-methyl-D-aspartate receptor encephalitis who received intensive inpatient neurorehabilitation. RESULTS: On average, patients were 10.6 yrs of age (range, 2-18 yrs) at the time of symptom onset. Average time to treatment from symptom onset was 27.2 days (range, 5-91 days). Patients displayed significant improvements between admission and discharge Functional Independence Measure for Children (WeeFIM) Developmental Functional Quotient (DFQ) scores across patients (P < 0.01). Mean Functional Independence Measure for Children Total Developmental Functional Quotient score at admission was 28.6 (range, 15.0-62.6) and at discharge was 54.3 (range, 14.2-91.9). Younger age at onset, seizures, and number of treatments received were associated with worse functional outcomes at discharge. Time to initiate treatment was not found to be associated with early functional outcomes. CONCLUSION: Pediatric patients diagnosed with anti-N-methyl-D-aspartate receptor encephalitis displayed significant functional gains during inpatient rehabilitation, despite persistent functional deficits at discharge, suggesting the need for ongoing monitoring and intervention. TO CLAIM CME CREDITS: Complete the self-assessment activity and evaluation online at http://www.physiatry.org/JournalCME CME OBJECTIVES: Upon completion of this article, the reader should be able to (1) Recognize the clinical presentation of anti-N-methyl-D-aspartate receptor encephalitis in pediatric patients, (2) Appreciate the role of rehabilitation in the care of the pediatric patient with anti-N-methyl-D-aspartate receptor encephalitis, and (3) Identify demographic and clinical variables that predict poor functional outcomes after rehabilitation in pediatric patients with anti-N-methyl-D-aspartate receptor encephalitis. LEVEL: Advanced. ACCREDITATION: The Association of Academic Physiatrists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.The Association of Academic Physiatrists designates this Journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
引用
- Howarth RA, Vova J, Blackwell LS, et al. Early Functional Outcomes for Pediatric Patients Diagnosed with Anti-N-Methyl-D-Aspartate Receptor Encephalitis during Inpatient Rehabilitation. Am J Phys Med Rehabil. 2019. PMID: 30379652. doi:10.1097/PHM.0000000000001087
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。